Automated Carbon Dioxide Angiography in Fenestrated/Branched Endovascular Abdominal Aortic Aneurysm Repair

Launched by UPPSALA UNIVERSITY · Oct 24, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to use Carbon Dioxide (CO2) for imaging during a specific type of surgery called fenestrated or branched endovascular aortic repair (F/B-EVAR). This surgery is used to treat thoracoabdominal aortic aneurysms (TAAAs), which are bulges in a major artery in the chest and abdomen. The trial aims to see how safe it is to use an automated CO2 injector during these procedures, especially since using CO2 can help reduce the risk of kidney problems that can happen with traditional contrast agents. Researchers will also focus on how well the images taken during the procedure show the important blood vessels that need to be treated.

To qualify for this study, participants should be between the ages of 65 and 75 and have a medical need for this type of surgery according to accepted guidelines. They also need to provide consent to participate. However, individuals with severe lung disease, certain heart conditions, or those currently involved in other studies will not be eligible. Participants in the trial can expect to help improve the safety and effectiveness of this procedure for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with indication for treatment of complex TAAA according to accepted international guidelines
• • Provided informed consent
• Exclusion Criteria:
• • Severe COPD (Chronic Obstructive Pulmonary Disease), GOLD Stage 3 and 4
• • Known atrium- or ventricular septal defect with right-left-shunt
• • Current participation in other interventional studies